safety of glp-1 receptor agonists for the Reduction Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes Exploring the Side Effects of

Furthermore, the cardiovascular benefits emerged early in treatment, preceding significant weight loss, suggesting that the cardiovascular effects may be mediated, at least partially, by other salutary processes in atherosclerotic protection

[DOI] [PMC free article] [PubMed] [Google Scholar] 34.Li W., Zhou Q., Cong Z., Yuan Q., Li W., Zhao F., Xu H.E., Zhao L.H., Yang D., Wang M.W

519 Specifically, high blood glucose-induced insulin resistance in CRC cells leads to increased BMP4 expression, which activates the BMP4-Smad1/5/8 signaling pathway

Retatrutide is not yet FDA-approved

GLP-1 RAs may also help prevent renal complications of type 2 diabetes

The N-terminal region of GLP-1 is considered critical for receptor activation, whereas the C-terminal region predominantly facilitates receptor binding